Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accurate, alternate, alternative, American, animal, arbitration, breached, casualty, chain, Collaboration, competition, complex, comply, concealed, confidence, confidential, confidentiality, convenience, costly, covered, damage, defending, delay, delaying, dermal, deviated, diligence, discovered, disqualification, disrupted, event, expiry, face, fail, favorable, fraudulent, freedom, fulfill, function, gain, grafting, guarantee, harm, harmed, impose, independently, individual, institute, intake, jurisdiction, lengthy, licensor, licensure, lose, Mexico, Mustard, negotiate, noncompliance, outcome, outflow, pivotal, pose, preclinical, preclude, prevent, privacy, profile, prolong, protocol, qualifying, quality, recall, reinstated, rely, reputation, reputational, reveal, review, Rule, safe, scheduling, scientific, secondary, Similarly, size, source, store, submission, substantive, suffer, Sulfur, suspension, testing, track, ultimately, unauthorized, uncertain, undetected, unforeseen, unsuccessful, upfront, usable
Removed:
cellular, compliance, comprising
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Exhibit 10.1 - 6TH Amendment to Distribution Agreement - Orsini
- 10.2 Exhibit 10.2 - 1ST Amendment to Dispensing Agreement - Allcare
- 10.9 Exhibit 10.9 - Mediwound License Agreement
- 10.10 Exhibit 10.10 - Mediwound Supply Agreement
- 10.11 Exhibit 10.11 Amended and Restated Employment Agreement - M. Halpin
- 10.12 Exhibit 10.12
- 31.1 Exhibit 31.1 - CEO Certification 6.30.19
- 31.2 Exhibit 31.2 - CFO Certification 6.30.19
- 32.1 Exhibit 32.1 - CEO Sox Certification 6.30.19
- 32.2 Exhibit 32.2 - CFO Sox Certification 6.30.19
- Download Excel data file
- View Excel data file
Related press release
Associated VCEL transcripts
VCEL similar filings
Filing view
External links
EXHIBIT 32.2
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Vericel Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (“Section 906”), the following:
(1) The Report fully complies with the requirements of section 13(a) and 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 6, 2019
/s/ GERARD MICHEL | |
Gerard Michel | |
Chief Financial Officer and Vice President, Corporate Development | |
(Principal Financial Officer) |
A signed original of this written statement required by Section 906 has been provided to Vericel Corporation and will be retained by Vericel Corporation and furnished to the Securities and Exchange Commission or its staff upon request.